RBM35A, also known as ESRP1 (epithelial splicing regulatory protein 1), plays a pivotal role in the regulation of alternative splicing, orchestrating the complex post-transcriptional modifications essential for the diversity and functionality of proteins within the cellular milieu. The RNA-binding protein navigates the intricate landscape of RNA processing, asserting its influence on the maturation and diversity of mRNA, a process fundamental to cellular function and complexity.
Chemicals that modulate RNA-binding proteins, including RBM35A, are typically involved in affecting RNA processing and splicing events. For instance, compounds like pladienolides and spliceostatin A, though not characterized specifically as RBM35A activators, have shown the capacity to intervene in RNA splicing by targeting the SF3B complex of the spliceosome. Other agents like isoginkgetin, a biflavonoid compound, and derivatives like E7107, though general in their action, provide insights into the chemical modulation of RNA splicing and processing. These chemicals, with their varied structures and mechanisms of action, underscore the diversity and complexity of compounds that can potentially interface with the world of RNA processing and, by extension, the activity of RNA-binding proteins like RBM35A.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Derived from a microbial source, it binds to the SF3B complex and inhibits splicing. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A biflavonoid compound that has been reported to inhibit splicing in vitro. | ||||||
FR901464 | 146478-72-0 | sc-507352 | 5 mg | $1800.00 | ||
A natural product that affects splicing by targeting the SF3B complex. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $270.00 | 5 | |
While primarily known as a DNA-damaging agent, its effects on the cellular response might indirectly influence RNA-binding proteins. | ||||||